Purchase Order 75D30124P20151

Award Date 9/19/24
Potential Completion Date 4/24/25
Potential Value $1M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to the University of Washington (UW) for non-medical cost estimates and injury morbidity services. The contract has a ceiling value of $242,281.00 and a performance period ending on August 30, 2024. The contract is not set aside for any socioeconomic categories. UW is a large public research university that frequently secures prime federal contracts and grants...
This is a $3,502,329.47 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) on September 30, 2014 for "Other Functions" with an ultimate completion date of September 30, 2019. The contract has a cost-no-fee pricing type and is not set aside for small businesses. UW is a large educational institution that has a history of providing a range of research, medical, and technical services to various federal agencies through...
This is a $240,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for EXOME SEQUENCING ANALYST SUPPORT services. The award has an ultimate completion date of April 21, 2025. UW is a large public research university that frequently competes for and wins federal contract and grant awards across various scientific and technological domains. This contract is not set aside. UW has significant experience providing...
This is a definitive federal contract award made by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) to conduct a prospective observational cohort study characterizing the burden of COVID-19. The contract has a ceiling value of $1,093,591.76 and a completion date of December 31, 2021. The contract was awarded on September 3, 2020 and does not have a set-aside designation. As a leading research institution, UW has extensive experience providing research...
This is a $116,276.26 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Washington for unspecified "other functions" with no set-aside designation. The University of Washington is a leading public research university that has received numerous prime federal contracts and grants to provide a range of research, technical, and healthcare services across various federal agencies. While...
This is a $4,096,310.00 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for COVID-19 genome sequencing services. The contract has an ultimate completion date of April 19, 2022. UW is a large public research university with extensive experience supporting federal agencies across various disciplines. The contract is not set aside for small businesses. UW has held several Indefinite Delivery Vehicles (IDVs) with the...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for Sexually Transmitted Infections Impact Research Consortium Support Services. The contract has a ceiling value of $10,011,255.33 and a period of performance through April 2025. The contract is not set aside for any specific business type. UW, as a prominent research university, will provide a variety of scientific, medical, and technological services to...
This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the University of Washington. The contract is for $116,617.00 and has an ultimate completion date of September 29, 2017. The award is for a non-R&D project titled "IDENTIFYING COMMENSURATION BIAS IN NIH/CSR PEER REVIEW" and does not have a set-aside designation. The University of Washington is a leading...
This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to the University of Washington (UW) for $335,770.00. The contract is for UWA UNOLS services with a period of performance through July 31, 2029. UW is a prominent public research university that has extensive experience executing complex, multidisciplinary federal research projects across scientific domains. The award is not set aside and represents the university's ability to compete...
This is a $26,116,402.00 definitive cost no fee contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the University of Washington (UW). The contract is for biomedical (applied/exploratory) services. It does not have a set-aside designation. UW is a leading public research university that leverages its academic and research capabilities to support various federal agencies through contracts and grants. The university often serves...

This is a $1,038,529 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for "NON-MEDICAL COST OF INJURY MORBIDITY" services. The contract has an ultimate completion date of April 24, 2025.

UW is a prominent research university that has established itself as a leading institution in fields such as biomedical research, oceanography, climate science, and technology development. The university has a strong track record of executing federal contracts and grants across various government agencies, including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense.

This contract is not associated with a set-aside program. However, UW does hold an indefinite delivery/indefinite quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute for the Multi-Ethnic Study of Atherosclerosis (MESA) program, which has a potential total value of $500 million over 10 years and provides centralized omics resource DNA methylation services.

Generated 4/27/25, 12:54 AM